Acetazolamide Per os for Decompensation of Heart Failure

PHASE4RecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

August 28, 2025

Study Completion Date

December 1, 2025

Conditions
Chronic Heart Failure
Interventions
DRUG

Acetazolamide

Acetazolamide is a diuretic with a mild diuretic effect. Inhibits the enzyme carbonic anhydrase in the proximal convoluted tubule of the nephron. Increases urinary excretion of sodium, potassium, bicarbonate ions, does not affect the excretion of chlorine ions; causes an increase in urine pH.

Trial Locations (1)

443099

RECRUITING

Samara state medical university, Samara

All Listed Sponsors
lead

Samara State Medical University

OTHER